Company

Sudo Biosciences

Biotechnology Research 10401 N Meridian St 24 employees

Employees: 24
Contacts: 2
Emails: 2

www.sudobio.com LinkedIn Crunchbase

Sudo Biosciences Overview

Headquarters: 10401 N Meridian St
Website: www.sudobio.com
Industry: Biotechnology Research
Employees: 24
Funding: 30.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in study management will be instrumental in the successful execution of our programs and studies.

About Sudo Biosciences

Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives. Our lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain. TYK2 is a key mediator in cytokine signaling pathways that have been linked to a broad range of immune-mediated inflammatory conditions.

Sudo Biosciences Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Sudo Biosciences Org Chart

Sample employees and titles

Name	Title	Location	Contact
Sarah Loughrey-Jennings	Clinical Program Manager	United Kingdom	Email
Gordon Mcmurray	Cdo Sudo Biosciences, Cso Pioneer	Greater London, England, United Kingdom	Email
Vassilios Aslanis	Vice President - Head of Clinical		View
Roy Gray	VP Head of Nonclinical Development		View